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SUMMARY
Introduction Preterm delivery (PTD), defined as a delivery between 24th and 37th completed week, in-
creases the risk of neonatal morbidity and mortality. There is a growing body of evidence that the in-
trauterine infection as well as cervicovaginal bacterial infections and Chlamydia infections are possible 
causes of preterm delivery. Host response to cervicovaginal and/or intrauterine infections is coupled 
with a release of various inflammatory mediators, many of which are cytokines.
Objective The aim of the study was to find out if cervical infection influenced the serum levels of 
interferon-γ (IFN-γ), interleukin 8 (IL-8) and interleukin 10 (IL-10) in patients with the clinical symptoms 
of the imminent preterm delivery.
Methods A total of 128 pregnant women (from 24 to 30 weeks of gestation) with the clinical symptoms 
of the imminent preterm delivery were divided in: study group – 85 patients with the cervical infection, 
and control group – 43 patients without the cervical infection. The level of cytokines in the serum was 
measured with commercial ELISA tests.
Results No significant difference could be found in serum levels of IFN-γ (p=0.632), IL-8 (p=0.712) and 
IL-10 (p=0.676) between these two investigated groups.
Conclusion The results of our study suggest that there is no significant difference in serum IFN-γ, IL-8 and 
IL-10 concentrations between pregnant women with the symptoms of the imminent preterm delivery 
who had and had no cervical infection.
Keywords: interferon gamma; interleukin 8; interleukin 10; preterm delivery; bacterial infection; Candida; 
Chlamydia trachomatis
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INTRODUCTION
Preterm delivery (PTD), defined as delivery 
prior to 37 completed weeks of gestation, 
increases the risk of neonatal morbidity and 
mortality [1]. It is now well accepted that in-
trauterine infection causes a significant pro-
portion of spontaneous PTDs, particularly ear-
lier ones. Bacteria can ascend from the lower 
genital tract before or during pregnancy, infect 
the membranes and initiate an inflammatory 
response culminating in preterm labor (PTL) 
or preterm premature rupture of membranes 
(PPROM) [2]. Cytokines are a diverse group 
of soluble proteins that mediate inflammation 
and many other processes. These proteins ex-
hibit pleiotropy and functional redundancy, up 
and down-regulating one another to result in 
complex networks involved in the establish-
ment and maintenance of pregnancy [3] and 
complications such as miscarriage, preeclamp-
sia and spontaneous PTD [2]. A long-standing 
paradigm classifies cytokines based on their T-
cell lineage as Th1 or Th2. Normal pregnancy 
has been characterized as Th2-dominant state 
[4], although the timecourse of the expected 
shift to Th2 dominance in peripheral blood is 
not clear [5]. Host response to cervicovaginal 
and/or intrauterine infections is represented 
with a release of various inflammatory media-
tors, many of which are cytokines [6]. Pro-in-
flammatory cytokines, in the settings of genital 
infection, could have an important role in the 
chain of events that lead to the preterm de-
livery, switching the Th1/Th2 relationship to 
the Th1 side which can be devastating for the 
foetus [7, 8].
In 1992, Shimoya et al. [9] showed the pres-
ence of interleukin 8 (IL-8) in trophoblast 
cells and macrophages in first, as well as in the 
third trimester of pregnancy with the elevated 
expression of this cytokine during the course 
of chorioamnionitis. Interleukin-10 (IL-10) 
is a pleiotropic anti-inflammatory cytokine 
involved in limiting and terminating inflam-
matory responses, recently defined as a ‘gover-
nor’ of inflammation [10] Activated Th2 cells 
are the major source of IL-10 production, and 
IL-10 has been classically considered a Th2 
cytokine marker. During pregnancy, sources 
of IL-10 include cytotrophoblasts, syncytio-
trophoblasts, and chorion as well as decidual   
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mononuclear cells/macrophages and decidual natural 
killer (NK) cells [11, 12, 13].
Pro-inflammatory cytokine, interferon gamma (IFN-γ), 
along with the interleukin 12 is a major promoter of dif-
ferentiation of naïve Th cells into Th1 cell subpopulation 
that can induce the creation of hostile environment for 
the foetus. IFN-γ plays important roles in diverse cellular 
processes, including activating innate and adaptive im-
mune responses, inhibiting cell proliferation, and inducing 
apoptosis [14]. It is also crucial in the immune responses 
against pathogens and immunosurveillance of tumours 
[15]. Cytokines in plasma or serum from healthy, non-
pregnant adults are predominantly pro-inflammatory (Th1 
type). Gradually, across the duration of normal pregnancy, 
women invert this ratio and become type 2 (regulatory) 
cytokine dominant in the third trimester [16]. Women 
showing type 1-dominant cytokine profiles in the third 
trimester are considered to have threatened pregnancies 
[16]. There are multiple sources for plasma cytokines in 
pregnant women, including trophoblasts, maternal en-
dothelial cells, and circulating leukocytes. By the third 
trimester, the circulating leukocytes have acquired an 
activated phenotype, with gains in expression of CD11B, 
CD14, CD64, and intracellular reactive oxygen species. 
This has provided the concept that pregnancy is a pro-in-
flammatory state. Normally in late pregnancy, MHC class 
II expression on leukocytes is decreased, and IFN-γ levels 
are low [16]. A cascade of events proceeding from the Th1 
immune-dominance could either act through stimulation 
of the uterine contractions (through the activation of pros-
taglandins) or by softening the cervix and weakening the 
chorioamniotic membranes (through the action of metal-
loproteinases) thus leading to their rupture. Sialidases and 
prolidases are the enzymes produced by anaerobic bacteria 
which are likely involved in the pathogenesis of bacterial 
vaginosis. The action of these enzymes may potentially 
alter the immune signals.
Pro-inflammatory cytokines could be a good marker 
of the intrauterine infections, whereas anti-inflammatory 
cytokines could be very important for normal course of 
pregnancy [14].
OBJECTIVE
The aim of the study was to investigate if local cervical 
infection could influence the serum levels of IFN-γ, IL-8 
and IL-10 in pregnant women with the clinical symptoms 
of the imminent preterm delivery.
METHODS
The study enrolled 128 pregnant women at a gestational 
age ranging from 24 to 30 weeks of gestation (WG), admit-
ted at the Department of Gynecology and Obstetrics at the 
Clinical Center of Vojvodina (Novi Sad), with the clinical 
symptoms of the imminent preterm delivery (presence of 
contractions of the uterus, but without cervical ripening 
or an evident rupture of membranes). Gestational age was 
based on last menstrual period and was confirmed by an 
early first trimester ultrasonography. The protocol was 
approved by the Institutional Ethics Board of the Faculty 
of Medicine, University of Novi Sad and Clinical Centre 
of Vojvodina (Novi Sad). Each patient was provided with 
the informed consent. Investigated pregnant women were 
divided in two groups according to the following crite-
ria: 1) patients with the cervical bacterial infection (CB) 
or Candida infection (CI) or Chlamydial infection (Chl) 
(n=85, study group) and patients without CB, CI and Chl 
(n=43, control group).
Some other factors that can cause preterm delivery, such 
as general factors (mother diseases: cardiovascular diseases, 
preeclampsia, kidney diseases, urinary infections, diabetes 
mellitus; local factors: uterine malformation, cervical in-
sufficiency, uterine and adnexal tumours, Asherman’s syn-
drome, cervical conisation, other genital infections) and 
obstetric risk factors (multiple pregnancy, polyhydramnion) 
were excluded in all patients [17] Furthermore, the factors 
which can influence the level of interleukins in the serum, 
such as autoimmune diseases, hormonal disorders, special 
complications of hypersensitivity and infectious diseases 
were also excluded during the selection of patients.
Microbiological diagnosis was performed with direct 
cervical swab preparation coloured by methylene blue and 
by Gram stain. Cultivation of the material taken with cervi-
cal swab was performed by standard bacteriological tech-
niques (isolation and identification), while Candida was 
cultivated on Sabouraud agar plates. Presence of Chlamy-
dial infection was detected by Chromatographic immu-
noassay kit (BIOKIT S.A. LLICA d’ AMUNT, Barcelona, 
Spain) and by direct fluorescent microscopy (DIF test). All 
patients with positive cervical swab were treated with an-
tibiotics according to drug susceptibility test (mostly from 
cephalosporin or penicillin groups), after the samples were 
collected from the patients.
Serum samples preparation and immunoassay for IFN-γ, 
IL-8 and IL-10: Venous blood was collected from all patients 
during the first 24 hours after the first symptoms of preterm 
delivery. Serum was obtained by centrifugation at 4000g for 
15 minutes and stored at -20o C before use. Measurements of 
cytokines in the serum were performed by ELISA test (R&D 
Systems). Absorbance was measured in duplicates with a 
microplate reader (Beckman Coulter). The final concentra-
tion was expressed in pg/ml. Sensitivity of method was 8.0 
pg/ml for IFN-γ; 3.5 pg/ml for IL-8, and 3.9 pg/ml for IL-10.
Dexamethasone therapy (four intramuscular doses of 
6 mg given 12 hours apart) [18, 19] was administered in 
all patients for foetal lung maturation. In addition, the pa-
tients received tocolytic therapy (atosiban: amp. 0.9 ml iv. 
in bolus; after 2 amp. of 5 ml in 90 ml 0.9% NaCl in dura-
tion of 3 hours with the infusion pump; after 2 amp. of 5 
ml in 90 ml 0.9% NaCl in duration of 24 hours with the 
infusion pump) and sedatives from benzodiazepine group 
(2 times tbl. 5 mg or amp. 10 mg). All the aforementioned 
therapy was introduced 30 min after the maternal blood 
collection and there was no significant difference in that 
interval between the two groups of patients.     
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Statistical analysis was performed with the Statistical 
Package for Social Sciences (SPSS) for Windows. The re-
sults were statistically evaluated with the nonparametric 
Mann-Whitney test, and p-values less than 0.05 were con-
sidered statistically significant.
RESULTS
Maternal demographic characteristics (age of patients, 
gestational age, history of pregnancies and deliveries) in 
study group (SG) and control group (CG) were presented 
in Table 1. The isolated microbiological strains from cer-
vical swabs of patients from study group were shown in 
Table 2. The following microbes from study group have 
been identified: Chlamydia trachomatis in 27, Candida 
sp. in 18, Escherichia coli in 12, both Enterococcus and 
Staphylococcus sp. in 8, Klebsiella pneumoniae in 7 and 
Streptococcus agalactiae in 5 pregnant women.
Serum IFN-γ levels in patients from study and control 
groups were summarized in Table 3. IFN-γ was detected in 
32% of study cases and in 29% of the controls. The mean 
value of serum IFN-γ level in patients from the study 
group (pregnant women with the cervical infection) was 
5.13±17.45 pg/ml. In the control group, the mean IFN-γ 
value was 3.23±5.48 pg/ml. The mean value of serum 
IFN-γ level in study group was not significantly different 
from that in the control group (p=0.632).
Serum levels of IL-8 in patients from study and control 
groups were illustrated in Table 4. IL-8 was detected in 
study group in 53% of cases and in 41% of patients from 
the controls. The mean value of serum IL-8 level in study 
group (pregnant women with the cervical infection) was 
17.4±11.8 pg/ml. In the control group, the mean value of 
IL-8 level was 12.2±7.48 pg/ml. The mean value of serum 
IL-8 level in study group was not significantly different 
from that in the control group (p=0.712).
Serum levels of IL-10 in patients from study and control 
groups were demonstrated in Table 5. IL-10 was detected in 
study group in 61.4% of cases and in 65.7% of patients from 
the control group. The mean value of serum IL-10 level in pa-
tients from the study group (pregnant women with the cervi-
cal infection) was 19.4±14.9 pg/ml. In the control group, the 
mean value of serum IL-10 level was 21.2±9.58 pg/ml. The 
mean value of serum IL-10 level in study group was not sig-
nificantly different from that in the control group (p=0.676).
Pregnancy outcome in the investigated groups of patients 
was shown in Table 6. In the study group, there were 30 
(35.3%) preterm and 52 (61.1%) term deliveries, while in 
the control group, 17 women (39.5%) and 24 (55.8%) had 
preterm and in term deliveries, respectively. There were also 
3 deaths of infants (3.6%) recorded in the study group and 2 
(4.7%) in the controls. There was no statistically significant 
difference in distribution of pregnancy outcomes between 
two investigated groups of patients (p=0.875).
DISCUSSION
Cytokine pathways in pregnancy have been intensively in-
vestigated, with most studies examining the cytokines in 
Table 1. Demographic and pregnancy associated data of 128 pregnant women enrolled in the study
Characteristics
Limits Mean±SD
p
Study group Control group Study group Control group
Maternal age (years) 18–42 18–39 27.7±5.4 27.1±5.2 NS
Gestational age (weeks) 24–30 24–30 26.2±5.7 26.5±5.1 NS
Gravidity 1–12 1–6 2.3±1.8 2.1±1.5 NS
Parity 1–6 1–3 1.7±1.0 2.2±0.9 NS
NS – not significant
Table 2. Isolated microbes from cervical swabs of study group patients
Isolated microbe N (%)
Chlamydia trachomatis 27 (31.8)
Candida albicans 18 (21.2)
Escherichia coli 12 (14.1)
Staphylococcus sp. 8 (9.4)
Enterococcus sp. 8 (9.4)
Klebsiella pneumoniae 7 (8.2)
Streptococcus agalactiae 5 (5.9)
N – number of patients
Table 3. Serum levels of interferon-γ (pg/ml) in the investigated preg-
nant women
Group N Detectability Min Max Mean±SD
Study 85 28% 0.00 116.70 5.13±17.45
Control 43 30% 0.00 27.73 3.23±5.48
p=0.632
Table 4. Serum levels of interleukin 8 (pg/ml) in the investigated preg-
nant women
Group N Detectability Min Max Mean±SD
Study 85 53% 0.00 43.7 17.4±11.8
Control 43 41% 0.00 34.5 12.2±7.48
p=0.712
Table 5. Serum levels of interleukin 10 (pg/ml) in the investigated 
pregnant women
Group N Detectability Min Max Mean±SD
Study 85 61.4% 0.00 54.3 19.4±14.9
Control 43 65.7% 0.00 61.2 21.2±9.58
p=0.676
Table 6. Pregnancy outcomes in the investigated groups
Variable
Study group Control group
N % N %
Total number 85 100.0 43 100.0
Spontaneous preterm delivery 30 35.3 17 39.5
Term delivery 52 61.1 24 55.8
Death of infants 3 3.6 2 4.7
p=0.875  
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serum, cervical, vaginal or amniotic fluid in women who 
present with the preterm labor or had preterm prelabor 
rupture of membranes (PPROM) [2, 3, 20]. Over years, 
several cytokines in the maternal circulation, amniotic 
cavity and foetus have been tested for their use in the di-
agnostics of intra-amniotic and neonatal infections. Some 
studies point out that the maternal compartment differs 
from the foetal one and that the inflammatory responses 
in the foetal compartment are not necessarily reflected in 
maternal serum [21]. However, the diagnostic values of the 
maternal serum cytokines are not completely understood, 
especially in pregnancies with the imminent preterm de-
liveries and signs of localised cervical infection.
IFN-γ is defined as a pro-inflammatory cytokine belong-
ing to Th1 immunological profile. It is a major promoter of 
differentiation of naïve T cells into Th1 cell subpopulation. 
Almost all Th1 cells can produce IFN-γ, which predomi-
nantly activates antigen-presenting cells, macrophages, neu-
trophils and NK cells and stimulates production of other in-
terleukins such as IL-1, IL-6, IL-8, IL-18 and tumour necro-
sis factor α (TNF-α). In normal pregnancy at term, IFN-γ 
is not detectable in amniotic fluid and is found at low con-
centrations in plasma and in significant amount in placenta, 
amnion, and choriodecidua [22]. Wilke et al. [23] reported 
that women delivering preterm had lower plasma IFN-γ 
between weeks 20 and 25 of gestation than women deliver-
ing at term, and that these levels tended to rise rather than 
decline between mid-gestation and birth. Not all studies find 
cytokine differences between these groups of women, or use 
common assay techniques. Even in women with the active 
malarial infection within their placentas, IFN-γ levels could 
not be correlated with preterm delivery [24]. In the paper 
of Piccinni [25], the concentrations of IFN-γ produced by 
decidual T cells of women with the unexplained recurrent 
abortions (URA) and normal pregnancy did not differ. No 
increased production of IFN-γ by decidual T cells was found 
in URA, as could be expected because of the potential role of 
Th1-type cytokines on allograft rejection, bearing in mind 
the paradigm of the foetus as the semi-allograft. Therefore, it 
might be appropriately concluded that ‘there is a bias against 
type 1 cytokine expression and function in pregnancy’. Type 
2 cytokines may not be essential to pregnancy per se, but 
they may provide a bias away from type 1 cytokines. Surely 
Th1 cytokines, depending on their time of expression, the 
stage of gestation and their relative concentrations, could 
have a positive influence on pregnancy.
The status of pro-inflammatory cytokines in the ma-
ternal serum or in the amniotic fluid during infection 
and shortly before parturition has also been extensively 
described [26]. In the study of Alvarez de la Rosa et al. [27], 
the authors noted that the concentration of the maternal 
serum interleukins 1, 6 and 8 in women 24-37 weeks who 
were in preterm labor, was elevated but not significantly 
in comparison to those who were not in labor. Torbe et al. 
[21] found in their study that only the concentrations of 
IL-1β were significantly higher in the serum of mothers 
with preterm delivery in conjunction with the early onset 
of infection in the newborns. IL-10 is believed to be a key 
cytokine for the maintenance of pregnancy. Production 
of this cytokine is significantly reduced in the placenta at 
term without labor compared with that in the first and 
second trimester tissues, suggesting that downregulation of 
IL-10 is a physiological event that favours an inflammatory 
state around the time of the onset of labor [28]. Cytokine 
and their receptor polymorphisms may explain some of the 
risk variations between women. High secretory genotypes 
of IFN-γ and IL-10 have been associated with an increased 
risk of the recurrent early pregnancy loss [29].
One can assume that the serum measurement of IFN-γ, 
IL-8 and IL-10 concentrations in women with the cervical 
infections and preterm delivery is of limited significance. 
Local alterations in cytokine profiles tend to remain rela-
tively compartmentalised: indeed, although cervical mucus 
levels of some cytokines, like IL-8, are significantly higher 
in patients prior to miscarriage, these alterations are not 
always reflected in the circulation. [30] On the other hand, 
induction of Th1 immune response (IFN-γ being one of its 
major representatives), could be driven by multiple factors 
and cervicovaginal infection is only one of it. Once a chain 
of events for preterm delivery has been initiated, there are 
no major differences in cytokines concentrations proposed 
to have a role in it, regardless of the cause that triggered 
the process of preterm delivery.
CONCLUSION
The results of our study suggest that there is no significant 
difference in serum IFN-γ, IL-8 and IL-10 concentrations 
between pregnant women with the symptoms of the immi-
nent preterm delivery who had and had no cervical infec-
tion. The conclusion may be that the physiologic cytokine 
network in circulation during pregnancy is irrespective of 
the presence of the cervicovaginal infections. Possible ex-
planation for that fact could be the compartmentalisation 
of the immune response during the timecourse of the geni-
tal infection. Second explanation for our findings could 
be the fact that the induction of Th1 immune response 
(IFN-γ being one of the major representatives), which cre-
ates the hostile environment for the foetus, could be driven 
by multiple factors. Once a chain of events for preterm 
delivery has been initiated, there are no major differences 
in responsible cytokines concentrations, regardless of the 
cause triggering the process of preterm delivery.
The reported studies on measurement of cytokines in 
maternal serum in preterm labour or in the presence of the 
infection are still rare and have involved a small number of 
patients, so further studies are needed with standardized 
methods and in larger sample sizes.
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КРАТАК САДРЖАЈ
Увод Пре  вре  ме  ни по  ро  ђај се де  фи  ни  ше као по  ро  ђај пре 
на  вр  ше  не 37. не  де  ље труд  но  ће. По  ја  ва пре  вре  ме  ног по  ро-
ђа  ја зна  чај  но по  ве  ћа  ва мор  би  ди  тет и мор  та  ли  тет но  во  ро-
ђен  че  та. Ис  тра  жи  ва  ња у све  ту по  след  њих го  ди  на ука  зу  ју 
на зна  чај ин  тра  у  те  ру  сне, цер  ви  ко-ва  ги  нал  не бак  те  риј  ске и 
хла  ми  ди  јал  не ин  фек  ци  је у на  стан  ку пре  вре  ме  ног по  ро  ђа  ја. 
Од  го  вор до  ма  ћи  на на ин  тра  у  те  ру  сну, од  но  сно цер  ви  ко-
ва  ги  нал  ну ин  фек  ци  ју пра  ћен је осло  ба  ђа  њем раз  ли  чи  тих 
ин  фла  ма  тор  них ме  ди  ја  то  ра, од ко  јих не  ки при  па  да  ју гру  пи 
ци  то  ки  на.
Циљ ра  да Циљ ис  тра  жи  ва  ња је био да се утвр  ди да ли ин-
фек  ци  ја гр  ли  ћа ма  те  ри  це ути  че на ни  во ин  тер  фе  ро  на га-
ма (IFN-γ), ин  тер  ле  у  ки  на 8 (IL-8) и ин  тер  ле  у  ки  на 10 (IL-10) у 
се  ру  му же  на с кли  нич  ком сли  ком пре  те  ћег пре  вре  ме  ног 
по  ро  ђа  ја.
Ме  то  де ра  да У ис  пи  ти  ва  ње је укљу  че  но 128 труд  ни  ца (24–
30. не  де  ља труд  но  ће) с кли  нич  ком сли  ком пре  те  ћег пре  вре-
ме  ног по  ро  ђа  ја. Ис  пи  та  ни  це су свр  ста  не у сту  диј  ску гру  пу 
(85 же  на с ин  фек  ци  јом гр  ли  ћа ма  те  ри  це) и кон  трол  ну гру  пу 
(43 же  не без ове ин  фек  ци  је). Ни  во ци  то  ки  на у се  ру  му од  ре-
ђи  ван је ко  мер  ци  јал  ним те  сто  ви  ма ELI SA.
Ре  зул  та  ти Ни  је утвр  ђе  на ста  ти  стич  ки зна  чај  на раз  ли  ка у 
ни  во  и  ма IFN-γ (p=0,632), IL-8 (p=0,712) и IL-10 (p=0,676) у се-
ру  му из  ме  ђу две ис  пи  ти  ва  не гру  пе труд  ни  ца.
За  кљу  чак Ре  зул  та  ти ис  тра  жи  ва  ња су по  ка  за  ли да ни  је би  ло 
ста  ти  стич  ки зна  чај  не раз  ли  ке у кон  цен  тра  ци  ји ци  то  ки  на у 
се  ру  му из  ме  ђу труд  ни  ца са симп  то  ми  ма пре  те  ћег пре  вре-
ме  ног по  ро  ђа  ја са ин  фек  ци  јом гр  ли  ћа ма  те  ри  це и без ње.
Кључ  не ре  чи: ин  тер  фе  рон га  ма; ин  тер  ле  у  кин 8; ин  тер  ле-
у  кин 10; пре  вре  ме  ни по  ро  ђај; бак  те  риј  ска ин  фек  ци  ја; Can-
di da; Chlamydia trac ho ma tis
Интерферон гама, интерлеукин 8 и интерлеукин 10 у серуму жена са 
инфекцијом грлића материце и претећим превременим порођајем
Мирјана Богавац1,2, Снежана Бркић1,3, Дејан Ћелић1,4, Наташа Симин5, Јован Матијашевић1,6, Татјана Илић1,4
1Медицински факултет, Универзитет у Новом Саду, Нови Сад, Србија;
2Клиника за гинекологију и акушерство, Клинички центар Војводине, Нови Сад, Србија;
3Клиника за инфективне болести, Клинички центар Војводине, Нови Сад, Србија;
4Клиника за нефрологију и клиничку имунологију, Клинички центар Војводине, Нови Сад, Србија;
5Департман за хемију, Природно-математички факултет, Нови Сад, Србија;
6Институт за плућне болести, Сремска Каменица, Србија
Примљен • Received: 17/03/2011  Ревизија • Revision: 28/05/2013  Прихваћен • Accepted: 19/06/2013
Bogavac M. et al.  IFN-γ, IL-8 and IL-10 in Serum of Patients with the Cervical Infection and Symptoms of the Imminent Preterm Delivery